DENVER, Sept. 10, 2019 /PRNewswire/ -- CereHealth Corporation through its subsidiary CereScan ®, a national network of functional brain imaging and analytics centers, announced today that it has ...
Parkinson’s disease (PD), the second-most common neurodegenerative disease, is characterized by motor and nonmotor symptoms. PD is often misdiagnosed; inappropriate treatment due to misdiagnosis has ...
More than 10 million people worldwide live with Parkinson's disease, a progressive neurodegenerative disorder that affects movement, balance and thinking. Severity of the disease is measured through ...
Study: Smartphone-based prediction of dopaminergic deficit in prodromal and manifest Parkinson’s disease. Image Credit: mozakim / Shutterstock.com Parkinson’s disease (PD) is a neurodegenerative ...
TEXAS (KIAH) – Nearly one million people in the U.S. are living with Parkinson’s disease (PD). More than 52,000 are Texans. Parkinson’s is the second-most common neurodegenerative disease after ...
The effects of high and low consumption of caffeine on the brain’s dopamine transporter binding in patients diagnosed with Parkinson’s disease. Regular high caffeine consumption affects dopamine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results